A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 457-464

  Zahn, Roland C ^a   Schelp, Ina ^a   Utermöhlen, Olaf ^b   Von Laer, Dorothea ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; GENOMIC RNA; PROTEIN ADAR1 L; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RNA;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS INFECTION; UPREGULATION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CELL LINE; GENOME, VIRAL; GUANOSINE; HUMANS; IMMUNITY, NATURAL; L CELLS (CELL LINE); LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MUTATION; RNA, DOUBLE-STRANDED; RNA, VIRAL; UP-REGULATION;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS;

EID: 33846092075     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00067-06     Document Type: Article

References (42)

1. Andre, P., A. Kim, K. Khrapko, and W. G. Thilly. 1997. Fidelity and mutational spectrum of Pfu DNA polymerase on a human mitochondrial DNA sequence. Genome Res. 7:843-852.
2. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126.
3. Beyer, W. R., H. Miletic, W. Ostertag, and D. von Laer. 2001. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J. Virol. 75:1061-1064.
4. Beyer, W. R., D. Pöpplau, W. Garten, D. von Laer, and O. Lenz. 2003. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/SIP. J. Virol. 77:2866-2872.
5. Beyer, W. R., M. Westphal, W. Ostertag, and D. von Laer. 2002. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 76:1488-1495.
6. Biron, C. A., K. B. Nguyen, and G. C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263:7-27.
7. Bracho, M. A., A. Moya, and E. Barrio. 1998. Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J. Gen. Virol. 79:2921-2928.
8. Bruns, M., J. Cihak, G. Muller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130:247-251.
9. Cattaneo, R. 1994. Biased (A→I) hypermutation of animal RNA virus genomes. Curr. Opin. Genet. Dev. 4:895-900.
10. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
11. Franze-Fernandez, M. T., S. Iapalucci, N. Lopez, and C. Rossi. 1993. Subgenomic RNAs of Tacaribe virus, p. 113-131. In M. S. Salvato (ed.), Arenaviridae. Plenum Press, New York, NY.
12. George, C. X., M. V. Wagner, and C. E. Samuel. 2005. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J. Biol. Chem. 280:15020-15028.
13. Grande-Perez, A., E. Lazaro, P. Lowenstein, E. Domingo, and S. C. Manrubia. 2005. Suppression of viral infectivity through lethal defection. Proc. Natl. Acad. Sci. USA 102:4448-4452.
14. Grande-Perez, A., S. Sierra, M. G. Castro, E. Domingo, and P. R. Lowenstein. 2002. Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc. Natl. Acad. Sci. USA 99:12938-12943.
15. Higuchi, M., F. N. Single, M. Kohler, B. Sommer, R. Sprengel, and P. H. Seeburg. 1.993. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75: 1361-1370.
16. Jordan, R., L. Wang, T. M. Graczyk, T. M. Block, and P. R. Romano. 2002. Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells. J. Virol. 76:9588-9599.
17. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
18. Kawakubo, K., and C. E. Samuel. 2000. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 258:165-172.
19. Keohavong, P., and W. G. Thilly. 1989. Fidelity of DNA polymerases in DNA amplification. Proc. Natl. Acad. Sci. USA 86:9253-9257.
20. Kumar, M., and G. G. Carmichael. 1997. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. USA 94:3542-3547.
21. Lei, M., Y. Liu, and C. E. Samuel. 1998. Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. Virology 245: 188-196.
22. Liu, Y., K. C. Wolff, B. L. Jacobs, and C. E. Samuel. 2001. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. Virology 289:378-387.
23. Maas, S., T. Melcher, A. Herb, P. H. Seeburg, W. Keller, S. Krause, M. Higuchi, and M. A. O'Connell. 1996. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J. Biol. Chem. 271:12221-12226.
24. Meyer, B. J., and P. J. Southern. 1993. Concurrent sequence analysis of 5′ and 3′ RNA termini by intramolecular circularization reveals 5′ nontemplated bases and 3′ terminal heterogeneity for lymphocytic choriomeningitis virus mRNAs. J. Virol. 67:2621-2627.
25. Murphy, D. G., K. Dimock, and C. Y. Kang. 1991. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 181:760-763.
26. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
27. Patterson, J. B., and C. E. Samuel. 1995. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15:5376-5388.
28. Polson, A. G., and B. L. Bass. 1994. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J. 13: 5701-5711.
29. Polson, A. G., B. L. Bass, and J. L. Casey. 1996. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380:454-456.
30. Rueda, P., B. Garcia-Barreno, and J. A. Melero. 1994. Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 198:653-662.
31. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
32. Scadden, A. D., and C. W. Smith. 1997. A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence? EMBO J. 16:2140-2149.
33. Scadden, A. D., and C. W. Smith. 2001. Specific cleavage of hyper-edited dsRNAs. EMBO J. 20:4243-4252.
34. Schambach, A., H. Wodrich, M. Hildinger, J. Bohne, H. G. Krausslich, and C. Baum. 2000. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2:435-445.
35. Steinhauer, D. A., E. Domingo, and J. J. Holland. 1992. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 122:281-288.
36. Taylor, D. R., M. Puig, M. E. Darnell, K. Mihalik, and S. M. Feinstone. 2005. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79:6291-6298.
37. van Dijk, A. A., E. V. Makeyev, and D. H. Bamford. 2004. Initiation of viral RNA-dependent RNA polymerization. J. Gen. Virol. 85:1077-1093.
38. Ward, S. V., D. Markle, S. Das, and C. E. Samuel. 2002. The promoter-proximal KCS element of the PKR kinase gene enhances transcription irrespective of orientation and position relative to the ISRE element and is functionally distinct from the KCS-like element of the ADAR deaminase promoter. J. Interferon Cytokine Res. 22:891-898.
39. Watowich, S. S., R. I. Morimoto, and R. A. Lamb. 1991. Flux of the paramyxovirus hemagglutinin-neuraminidase glycoprotein through the endoplasmic reticulum activates transcription of the CRP78-BiP gene. J. Virol. 65:3590-3597.
40. Wong, S. K., S. Sato, and D. W. Lazinski. 2003. Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm. RNA 9:586-598.
41. Wong, T. C., M. Ayata, A. Hirano, Y. Yoshikawa, H. Tsuruoka, and K. Yamanouchi. 1989. Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis. J. Virol. 63:5464-5468.
42. Xu, C., B. Bailly-Maitre, and J. C. Reed. 2005. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Investig. 115:2656-2664.